{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:43:02Z","timestamp":1773200582430,"version":"3.50.1"},"reference-count":283,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.biotechadv.2023.108144","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T15:53:53Z","timestamp":1680710033000},"page":"108144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines"],"prefix":"10.1016","volume":"65","author":[{"given":"Rui","family":"Freitas","sequence":"first","affiliation":[]},{"given":"Andreia","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Miranda","sequence":"additional","affiliation":[]},{"given":"L\u00facio Lara","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Alexandre","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coi.2005.11.001","article-title":"Recognition of tumor glycans by antigen-presenting cells","volume":"18","author":"Aarnoudse","year":"2006","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01521345","article-title":"Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients","volume":"41","author":"Adluri","year":"1995","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046959","article-title":"Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses","volume":"7","author":"Ahl\u00e9n","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4155\/tde.14.74","article-title":"Antigen delivery by virus-like particles for immunotherapeutic vaccination","volume":"5","author":"Al-Barwani","year":"2014","journal-title":"Ther. Deliv."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0025","doi-asserted-by":"crossref","first-page":"8ra19","DOI":"10.1126\/scitranslmed.3000359","article-title":"In situ regulation of DC subsets and T cells mediates tumor regression in mice","volume":"1","author":"Ali","year":"2009","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101250","article-title":"A structurally simple vaccine candidate reduces progression and dissemination of triple-negative breast cancer","volume":"23","author":"Amedei","year":"2020","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0035","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1039\/C4SC03599B","article-title":"NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity","volume":"6","author":"Anderson","year":"2015","journal-title":"Chem. Sci."},{"issue":"25","key":"10.1016\/j.biotechadv.2023.108144_bb0040","doi-asserted-by":"crossref","first-page":"15029","DOI":"10.1073\/pnas.2432220100","article-title":"A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor","volume":"100","author":"Apostolopoulos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0045","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr1505","article-title":"Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]","volume":"8","author":"Apostolopoulos","year":"2006","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0050","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"28","key":"10.1016\/j.biotechadv.2023.108144_bb0055","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1002\/chem.201200364","article-title":"A C-linked disaccharide analogue of Thomsen-Friedenreich epitope induces a strong immune response in mice","volume":"18","author":"Awad","year":"2012","journal-title":"Chemistry"},{"issue":"14","key":"10.1016\/j.biotechadv.2023.108144_bb0060","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2174\/1389450119666180326122831","article-title":"Nanoparticles in cancer treatment: opportunities and obstacles","volume":"19","author":"Awasthi","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"53","key":"10.1016\/j.biotechadv.2023.108144_bb0065","doi-asserted-by":"crossref","first-page":"91734","DOI":"10.18632\/oncotarget.19433","article-title":"Over forty years of bladder cancer glycobiology: where do glycans stand facing precision oncology?","volume":"8","author":"Azevedo","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s43586-022-00128-4","article-title":"Glycoproteomics","volume":"2","author":"Bagdonaite","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.biotechadv.2023.108144_bb0075","doi-asserted-by":"crossref","first-page":"35848","DOI":"10.1038\/srep35848","article-title":"Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma","volume":"6","author":"Bailey","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0080","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1128\/IAI.73.9.5835-5841.2005","article-title":"Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein","volume":"73","author":"Baraldo","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.852147","article-title":"Glycoconjugate nanoparticle-based systems in cancer immunotherapy: novel designs and recent updates","volume":"13","author":"Barchi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118826","article-title":"Brewer\u2019s yeast polysaccharides \u2014 a review of their exquisite structural features and biomedical applications","volume":"277","author":"Bastos","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"15","key":"10.1016\/j.biotechadv.2023.108144_bb0095","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1039\/C9SC06334J","article-title":"Synthesis, conformational analysis and in vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp(2)-iminosugar fragment","volume":"11","author":"Bermejo","year":"2020","journal-title":"Chem. Sci."},{"issue":"12","key":"10.1016\/j.biotechadv.2023.108144_bb0100","first-page":"1204","article-title":"Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets","volume":"1","author":"Bhardwaj","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.03.020","article-title":"Advancements in prophylactic and therapeutic nanovaccines","volume":"108","author":"Bhardwaj","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0110","first-page":"175","article-title":"Synthetic peptide representing a T-cell epitope of CRM197 substitutes as carrier molecule in a haemophilus influenzae type B (Hib) conjugate vaccine","volume":"251","author":"Bixler","year":"1989","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0115","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr2841","article-title":"Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis","volume":"13","author":"Blixt","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0120","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1158\/0008-5472.CAN-04-2164","article-title":"DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses","volume":"65","author":"Bolesta","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold tumors: a therapeutic challenge for immunotherapy","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1021\/bc200606s","article-title":"Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines","volume":"23","author":"Brin\u00e3s","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.embor.7400705","article-title":"Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions","volume":"7","author":"Brockhausen","year":"2006","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0140","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1021\/acs.jmedchem.8b00312","article-title":"Synthesis, liposomal formulation, and immunological evaluation of a minimalistic carbohydrate-\u03b1-GalCer vaccine candidate","volume":"61","author":"Broecker","year":"2018","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Br\u00f6ker","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.biotechadv.2023.108144_bb0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/9781555819194.ch25","article-title":"Lectin receptors expressed on myeloid cells","author":"Brown","year":"2017","journal-title":"Myeloid Cells Health Dis."},{"issue":"47","key":"10.1016\/j.biotechadv.2023.108144_bb0155","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1002\/anie.200502179","article-title":"Thiooligosaccharide conjugate vaccines evoke antibodies specific for native antigens","volume":"44","author":"Bundle","year":"2005","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"37","key":"10.1016\/j.biotechadv.2023.108144_bb0160","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1002\/anie.200501818","article-title":"Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen","volume":"44","author":"Buskas","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0165","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1039\/b908664c","article-title":"Immunotherapy for cancer: synthetic carbohydrate-based vaccines","volume":"36","author":"Buskas","year":"2009","journal-title":"Chem. Commun. (Camb.)"},{"issue":"20\u221221","key":"10.1016\/j.biotechadv.2023.108144_bb0170","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1002\/ejoc.201100304","article-title":"Synthesis of Tn\/T antigen MUC1 glycopeptide BSA conjugates and their evaluation as vaccines","author":"Cai","year":"2011","journal-title":"Eur. J. Org. Chem."},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb0175","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/anie.201106396","article-title":"Variation of the glycosylation pattern in MUC1 glycopeptide BSA vaccines and its influence on the immune response","volume":"51","author":"Cai","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0180","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2008-05-155176","article-title":"The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement","volume":"112","author":"Caminschi","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molonc.2014.02.008","article-title":"Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells","volume":"8","author":"Carrascal","year":"2014","journal-title":"Mol. Oncol."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0190","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.bbagen.2018.05.013","article-title":"A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer","volume":"1862","author":"Carrascal","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643240","article-title":"Tolerogenic immunotherapy: targeting DC surface receptors to induce antigen-specific tolerance","volume":"12","author":"Castenmiller","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0200","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.R120.002093","article-title":"Meta-heterogeneity: evaluating and describing the diversity in glycosylation between sites on the same glycoprotein","volume":"20","author":"\u010caval","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0205","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nchembio.1650","article-title":"A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice","volume":"10","author":"Cavallari","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0210","first-page":"874","article-title":"Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study","volume":"6","author":"Chapman","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0215","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12951-022-01533-3","article-title":"A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","article-title":"Identification of tumor antigens with immunopeptidomics","volume":"40","author":"Chong","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121303","article-title":"Dendrimers in vaccine delivery: recent progress and advances","volume":"280","author":"Chowdhury","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/187152008783330815","article-title":"Glycoconjugates in cancer therapy","volume":"8","author":"Cipolla","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"6 Pt 3","key":"10.1016\/j.biotechadv.2023.108144_bb0235","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.biotechadv.2015.05.010","article-title":"Nanoengineering of vaccines using natural polysaccharides","volume":"33","author":"Cordeiro","year":"2015","journal-title":"Biotechnol. Adv."},{"issue":"18","key":"10.1016\/j.biotechadv.2023.108144_bb0240","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1039\/c1cc10192g","article-title":"Rational design of a Tn antigen mimic","volume":"47","author":"Corzana","year":"2011","journal-title":"Chem. Commun."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0245","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/1878-0261.12035","article-title":"Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours","volume":"11","author":"Cotton","year":"2017","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041664","article-title":"Target score-A proteomics data selection tool applied to esophageal cancer identifies GLUT1-Sialyl Tn glycoforms as biomarkers of cancer aggressiveness","volume":"22","author":"Cotton","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0255","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cbic.201300785","article-title":"Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping","volume":"15","author":"Crotti","year":"2014","journal-title":"Chembiochem"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0260","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20100223","article-title":"The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells","volume":"207","author":"Crozat","year":"2010","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2010.02.013","article-title":"Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro","volume":"144","author":"Cruz","year":"2010","journal-title":"J. Control. Release"},{"issue":"16","key":"10.1016\/j.biotechadv.2023.108144_bb0270","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.biomaterials.2012.02.036","article-title":"Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN","volume":"33","author":"Cruz","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biotechadv.2023.108144_bb0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-391858-1.00008-3","article-title":"Targeting nanoparticles to dendritic cells for immunotherapy","volume":"509","author":"Cruz","year":"2012","journal-title":"Methods Enzymol."},{"issue":"34","key":"10.1016\/j.biotechadv.2023.108144_bb0280","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: A review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb0285","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"issue":"28","key":"10.1016\/j.biotechadv.2023.108144_bb0290","doi-asserted-by":"crossref","first-page":"9622","DOI":"10.1021\/ja902607a","article-title":"Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates","volume":"131","author":"De Silva","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"issue":"232","key":"10.1016\/j.biotechadv.2023.108144_bb0300","doi-asserted-by":"crossref","first-page":"232ra251","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0305","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.4049\/jimmunol.145.9.3071","article-title":"Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine","volume":"145","author":"Donnelly","year":"1990","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.biotechadv.2023.108144_bb0310","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.7150\/thno.35059","article-title":"Glyco-dendrimers as intradermal anti-tumor vaccine targeting multiple skin DC subsets","volume":"9","author":"Duinkerken","year":"2019","journal-title":"Theranostics"},{"issue":"46","key":"10.1016\/j.biotechadv.2023.108144_bb0315","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1002\/anie.200501594","article-title":"A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response","volume":"44","author":"Dziadek","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"issue":"30","key":"10.1016\/j.biotechadv.2023.108144_bb0320","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1200\/JCO.2012.47.9303","article-title":"Adjuvant ganglioside GM2-KLH\/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial","volume":"31","author":"Eggermont","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0325","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146956","article-title":"Vaccines for immunoprevention of cancer","volume":"131","author":"Enokida","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2015.05.003","article-title":"New trends in guided nanotherapies for digestive cancers: a systematic review","volume":"209","author":"Fernandes","year":"2015","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.biotechadv.2023.108144_bb0335","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/elps.201500270","article-title":"Humoral response against sialyl-Le(a) glycosylated protein species in esophageal cancer: insights for immunoproteomic studies","volume":"36","author":"Fernandes","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.biotechadv.2023.108144_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118646","article-title":"Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential","volume":"570","author":"Fernandes","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040861","article-title":"Nucleolin-Sle A glycoforms as E-selectin ligands and potentially targetable biomarkers at the cell surface of gastric cancer cells","volume":"12","author":"Fernandes","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0350","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.7150\/thno.42480","article-title":"Esophageal, gastric and colorectal cancers: looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology","volume":"10","author":"Fernandes","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0355","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molonc.2013.03.001","article-title":"Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours","volume":"7","author":"Ferreira","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0360","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.carbpol.2015.05.079","article-title":"Structure-function relationships of immunostimulatory polysaccharides: a review","volume":"132","author":"Ferreira","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gpb.2021.03.005","article-title":"Glycoproteogenomics: setting the course for next-generation cancer neoantigen discovery for cancer vaccines","volume":"19","author":"Ferreira","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0370","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri.2017.140","article-title":"The dawn of vaccines for cancer prevention","volume":"18","author":"Finn","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201800386","article-title":"Repetitive batch mode facilitates enzymatic synthesis of the nucleotide sugars UDP-gal, UDP-GlcNAc, and UDP-GalNAc on a multi-gram scale","volume":"14","author":"Fisch\u00f6der","year":"2019","journal-title":"Biotechnol. J."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0380","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molimm.2004.07.011","article-title":"Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen","volume":"42","author":"F\u00f6rster-Waldl","year":"2005","journal-title":"Mol. Immunol."},{"issue":"20","key":"10.1016\/j.biotechadv.2023.108144_bb0390","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.1039\/D0NJ06021F","article-title":"Single-pot enzymatic synthesis of cancer-associated MUC16 O-glycopeptide libraries and multivalent protein glycoconjugates: a step towards cancer glycovaccines","volume":"45","author":"Freitas","year":"2021","journal-title":"New J. Chem."},{"issue":"Pt A","key":"10.1016\/j.biotechadv.2023.108144_bb0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpb.2015.02.008","article-title":"Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers","volume":"95","author":"Frenz","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0400","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tan.12900","article-title":"Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen","volume":"88","author":"Fu","year":"2016","journal-title":"Hla"},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb0405","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.7150\/thno.67409","article-title":"Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion","volume":"12","author":"Gaiteiro","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0410","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1039\/C6OB01931E","article-title":"Large-scale synthesis and structural analysis of a synthetic glycopeptide dendrimer as an anti-cancer vaccine candidate","volume":"15","author":"Ganneau","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110888","article-title":"A review on development of MUC1-based cancer vaccine","volume":"132","author":"Gao","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0420","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ni.2419","article-title":"Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages","volume":"13","author":"Gautier","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.22.012703.104558","article-title":"Self- and nonself-recognition by C-type lectins on dendritic cells","volume":"22","author":"Geijtenbeek","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cmdc.201700646","article-title":"A synthetic MUC1 anticancer vaccine containing mannose ligands for targeting macrophages and dendritic cells","volume":"13","author":"Glaffig","year":"2018","journal-title":"ChemMedChem"},{"issue":"18","key":"10.1016\/j.biotechadv.2023.108144_bb0435","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/anie.201006327","article-title":"A coordinated synthesis and conjugation strategy for the preparation of homogeneous glycoconjugate vaccine candidates","volume":"50","author":"Grayson","year":"2011","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0440","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jssc.202000878","article-title":"Glycomics and glycoproteomics: approaches to address isomeric separation of glycans and glycopeptides","volume":"44","author":"Gutierrez Reyes","year":"2021","journal-title":"J. Sep. Sci."},{"issue":"15","key":"10.1016\/j.biotechadv.2023.108144_bb0445","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1073\/pnas.0710799105","article-title":"Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching","volume":"105","author":"Guttormsen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0450","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/glycob\/cwv037","article-title":"Antibody recognition of carbohydrate epitopes\u2020","volume":"25","author":"Haji-Ghassemi","year":"2015","journal-title":"Glycobiology"},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/adhm.201400460","article-title":"CpG-loaded multifunctional cationic nanohydrogel particles as self-adjuvanting glycopeptide antitumor vaccines","volume":"4","author":"Hartmann","year":"2015","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1084\/jem.190.1.145","article-title":"Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo","volume":"190","author":"Haurum","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0465","first-page":"37","article-title":"Glycoengineering of mammalian expression systems on a cellular level","volume":"175","author":"Heffner","year":"2021","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0470","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-1119(93)90151-R","article-title":"Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3","volume":"128","author":"Hoess","year":"1993","journal-title":"Gene"},{"issue":"45","key":"10.1016\/j.biotechadv.2023.108144_bb0475","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1002\/anie.201003810","article-title":"Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue","volume":"49","author":"Hoffmann-R\u00f6der","year":"2010","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0480","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10719-020-09926-y","article-title":"Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins","volume":"37","author":"Hoffmann","year":"2020","journal-title":"Glycoconj. J."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0485","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0490","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1039\/C4CS00388H","article-title":"Towards the next generation of biomedicines by site-selective conjugation","volume":"45","author":"Hu","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.biotechadv.2023.108144_bb0495","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1021\/ja211725s","article-title":"A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy","volume":"134","author":"Huang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"15_suppl","key":"10.1016\/j.biotechadv.2023.108144_bb0500","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1200\/JCO.2016.34.15_suppl.1003","article-title":"Randomized phase II\/III trial of active immunotherapy with OPT-822\/OPT-821 in patients with metastatic breast cancer","volume":"34","author":"Huang","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000342","article-title":"Globo H-KLH vaccine adagloxad simolenin (OBI-822)\/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study","volume":"8","author":"Huang","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"58","key":"10.1016\/j.biotechadv.2023.108144_bb0510","doi-asserted-by":"crossref","first-page":"99161","DOI":"10.18632\/oncotarget.21959","article-title":"Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects","volume":"8","author":"Hutchins","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0515","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ptr.7348","article-title":"Immunomodulatory effects of polysaccharides from marine algae for treating cancer, infectious disease, and inflammation","volume":"36","author":"Hwang","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0520","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2859-9-61","article-title":"Production of glycoprotein vaccines in Escherichia coli","volume":"9","author":"Ihssen","year":"2010","journal-title":"Microb. Cell Factories"},{"issue":"6205","key":"10.1016\/j.biotechadv.2023.108144_bb0525","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1257530","article-title":"T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells","volume":"346","author":"Iijima","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0530","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/cimm.1995.1109","article-title":"Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes","volume":"163","author":"Inaba","year":"1995","journal-title":"Cell. Immunol."},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb0535","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nchembio.2007.25","article-title":"Robust immune responses elicited by a fully synthetic three-component vaccine","volume":"3","author":"Ingale","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020272","article-title":"Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics","volume":"26","author":"Jhaveri","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0545","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/156802608783378882","article-title":"Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics","volume":"8","author":"Johnson","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0550","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00262-004-0584-y","article-title":"Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn","volume":"54","author":"Kagan","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"issue":"41","key":"10.1016\/j.biotechadv.2023.108144_bb0555","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1002\/anie.200902564","article-title":"A synthetic vaccine consisting of a tumor-associated Sialyl-TN-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response","volume":"48","author":"Kaiser","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0560","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1002\/1097-0142(19911201)68:11<2438::AID-CNCR2820681119>3.0.CO;2-#","article-title":"Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma","volume":"68","author":"Kakeji","year":"1991","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0565","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0570","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1021\/acs.biochem.7b01099","article-title":"Malaria derived glycosylphosphatidylinositol anchor enhances anti-Pfs25 functional antibodies that block malaria transmission","volume":"57","author":"Kapoor","year":"2018","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0575","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41435-020-0105-9","article-title":"Emergence and significance of carbohydrate-specific antibodies","volume":"21","author":"Kappler","year":"2020","journal-title":"Genes Immun."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0580","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI119825","article-title":"Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein","volume":"100","author":"Karanikas","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0585","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00002371-200103000-00012","article-title":"Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection","volume":"24","author":"Karanikas","year":"2001","journal-title":"J. Immunother."},{"issue":"7335","key":"10.1016\/j.biotechadv.2023.108144_bb0590","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0595","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/intimm\/dxl022","article-title":"Expression of human DEC-205 (CD205) multilectin receptor on leukocytes","volume":"18","author":"Kato","year":"2006","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0600","first-page":"86","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb0605","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/10870","article-title":"Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses","volume":"17","author":"Kieber-Emmons","year":"1999","journal-title":"Nat. Biotechnol."},{"issue":"15","key":"10.1016\/j.biotechadv.2023.108144_bb0610","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.3390\/ijms22158035","article-title":"Combining cancer vaccines with immunotherapy: establishing a new immunological approach","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.biotechadv.2023.108144_bb0615","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/anie.200351099","article-title":"Synthesis of a C-glycoside analogue of sTn: an HIV- and tumor-associated antigen","volume":"42","author":"Kuberan","year":"2003","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0620","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.051623598","article-title":"Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice","volume":"98","author":"Kudryashov","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.biotechadv.2023.108144_bb0625","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1021\/acs.chemrev.8b00036","article-title":"\u201cOne-pot\u201d protection, glycosylation, and protection-glycosylation strategies of carbohydrates","volume":"118","author":"Kulkarni","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0630","article-title":"High sensitivity glycomics in biomedicine","volume":"e21730","author":"Lageveen-Kammeijer","year":"2021","journal-title":"Mass Spectrom. Rev."},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb0635","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2217\/nnm.15.7","article-title":"Biodegradable chitosan nanoparticles in drug delivery for infectious disease","volume":"10","author":"Landriscina","year":"2015","journal-title":"Nanomedicine (London)"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0640","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00262-016-1802-0","article-title":"The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity","volume":"65","author":"Laubreton","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0645","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/vaccines4020008","article-title":"Direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies","volume":"4","author":"Lehmann","year":"2016","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0650","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0655","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Sign. Transduct. Target. Therap."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0660","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0665","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acscentsci.5b00364","article-title":"Fully synthetic self-adjuvanting \u03b1-2,9-oligosialic acid based conjugate vaccines against group C meningitis","volume":"2","author":"Liao","year":"2016","journal-title":"ACS Cent. Sci."},{"issue":"12","key":"10.1016\/j.biotechadv.2023.108144_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.08.012","article-title":"Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases","volume":"35","author":"Lima","year":"2017","journal-title":"Urol. Oncol."},{"issue":"43","key":"10.1016\/j.biotechadv.2023.108144_bb0675","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1038\/s41388-018-0375-0","article-title":"C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer","volume":"37","author":"Lin","year":"2018","journal-title":"Oncogene"},{"issue":"3\u20134","key":"10.1016\/j.biotechadv.2023.108144_bb0680","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10719-011-9331-8","article-title":"A structurally diversified linker enhances the immune response to a small carbohydrate hapten","volume":"28","author":"Lipinski","year":"2011","journal-title":"Glycoconj. J."},{"issue":"5\u20136","key":"10.1016\/j.biotechadv.2023.108144_bb0685","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10719-012-9399-9","article-title":"Carbohydrate-based cancer vaccines: target cancer with sugar bullets","volume":"29","author":"Liu","year":"2012","journal-title":"Glycoconj. J."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0690","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1021\/acs.bioconjchem.5b00150","article-title":"Glycopeptide nanoconjugates based on multilayer self-assembly as an antitumor vaccine","volume":"26","author":"Liu","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0695","first-page":"280","article-title":"The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data","volume":"27","author":"Liu","year":"2017","journal-title":"Glycobiology"},{"issue":"68","key":"10.1016\/j.biotechadv.2023.108144_bb0700","doi-asserted-by":"crossref","first-page":"9486","DOI":"10.1039\/C7CC04386D","article-title":"Potentiating the immune response of MUC1-based antitumor vaccines using a peptide-based nanovector as a promising vaccine adjuvant","volume":"53","author":"Liu","year":"2017","journal-title":"Chem. Commun. (Camb.)"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0705","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/jcmm.14117","article-title":"Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0710","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/acsabm.1c00111","article-title":"Robust immune responses elicited by a hybrid adjuvant based on \u03b2-glucan particles from yeast for the hepatitis B vaccine","volume":"4","author":"Liu","year":"2021","journal-title":"ACS Appl. Bio. Mater."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0715","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.4049\/jimmunol.166.4.2849","article-title":"Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a Tri-Tn glycotope","volume":"166","author":"Lo-Man","year":"2001","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.biotechadv.2023.108144_bb0720","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1158\/0008-5472.CAN-04-0252","article-title":"A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates","volume":"64","author":"Lo-Man","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0725","first-page":"1539","article-title":"Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008","volume":"8","author":"Lu","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0730","series-title":"Glycosylation Engineering of Biopharmaceuticals: Methods and Protocols","first-page":"19","article-title":"Engineering a human-like glycosylation to produce therapeutic glycoproteins based on 6-linked sialylation in CHO cells","author":"Ma\u00ef","year":"2013"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0735","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2018.10.016","article-title":"Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules","volume":"49","author":"Maizels","year":"2018","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.biotechadv.2023.108144_bb0740","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.18632\/oncotarget.28083","article-title":"P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses","volume":"12","author":"Makhoul","year":"2021","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.biotechadv.2023.108144_bb0745","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1021\/ja00277a037","article-title":"Bimolecular chemistry of macromolecules: synthesis of bacterial polysaccharide conjugates with Neisseria meningitidis membrane protein","volume":"108","author":"Marburg","year":"1986","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb0750","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/08916934.2017.1373766","article-title":"Effects of immunomodulators on the response induced by vaccines against autoimmune diseases","volume":"50","author":"Marciani","year":"2017","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0755","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1039\/C5SC04039F","article-title":"Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment","volume":"7","author":"Mart\u00ednez-S\u00e1ez","year":"2016","journal-title":"Chem. Sci."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0760","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jaci.2018.07.030","article-title":"Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity","volume":"142","author":"Mathiesen","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0765","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2004.12.001","article-title":"Ligand recognition by antigen-presenting cell C-type lectin receptors","volume":"17","author":"McGreal","year":"2005","journal-title":"Curr. Opin. Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0770","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1039\/C5SC00952A","article-title":"Convergent chemo-enzymatic synthesis of mannosylated glycopeptides; targeting of putative vaccine candidates to antigen presenting cells","volume":"6","author":"McIntosh","year":"2015","journal-title":"Chem. Sci."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0775","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.immuni.2016.12.001","article-title":"The heterogeneity of Ly6C(hi) monocytes controls their differentiation into iNOS(+) macrophages or monocyte-derived dendritic cells","volume":"45","author":"Menezes","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0780","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2011.11.002","article-title":"Targeted nanotherapy for induction of therapeutic immune responses","volume":"18","author":"Metcalfe","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0785","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1428157","article-title":"Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial","volume":"7","author":"Michels","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0790","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/molecules23061451","article-title":"Protein carriers for Glycoconjugate vaccines: history, selection criteria, characterization and new trends","volume":"23","author":"Micoli","year":"2018","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.biotechadv.2023.108144_bb0795","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1002\/chem.200800203","article-title":"Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines","volume":"14","author":"Miermont","year":"2008","journal-title":"Chemistry"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0800","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10549-015-3425-0","article-title":"Relevance of \u03b2Gal-\u03b2GalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients","volume":"151","author":"Milde-Langosch","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0805","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1634\/theoncologist.2010-0307","article-title":"Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer","volume":"16","author":"Miles","year":"2011","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0810","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ni.2370","article-title":"Deciphering the transcriptional network of the dendritic cell lineage","volume":"13","author":"Miller","year":"2012","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb0815","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/glycob\/cwaa067","article-title":"ISOGlyP: de novo prediction of isoform-specific mucin-type O-glycosylation","volume":"31","author":"Mohl","year":"2021","journal-title":"Glycobiology"},{"issue":"16","key":"10.1016\/j.biotechadv.2023.108144_bb0820","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.vaccine.2007.01.072","article-title":"Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma","volume":"25","author":"Monzavi-Karbassi","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0825","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/erv.11.20","article-title":"CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer","volume":"10","author":"Morse","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"14","key":"10.1016\/j.biotechadv.2023.108144_bb0830","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1158\/1078-0432.CCR-11-0891","article-title":"Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with toll-like receptor stimulation to induce immunity to self-antigens in cancer patients","volume":"17","author":"Morse","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0835","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1271\/bbb.70.1049","article-title":"Enzymatic synthesis of oligosaccharides and neoglycoconjugates","volume":"70","author":"Murata","year":"2006","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"40","key":"10.1016\/j.biotechadv.2023.108144_bb0840","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1016\/j.vaccine.2020.07.039","article-title":"Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra\u00ae) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016","volume":"38","author":"Myers","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0845","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/eji.201142086","article-title":"Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation","volume":"42","author":"Napoletano","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb0850","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/js980070s","article-title":"Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses","volume":"87","author":"Newman","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0855","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1021\/acs.bioconjchem.5b00365","article-title":"Exploring the effect of conjugation site and chemistry on the immunogenicity of an anti-group B streptococcus glycoconjugate vaccine based on GBS67 pilus protein and type V polysaccharide","volume":"26","author":"Nilo","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0860","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2008.09.032","article-title":"Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes","volume":"47","author":"Ninkovic","year":"2009","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0865","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1039\/B503237G","article-title":"Functionalized foldamers: synthesis and characterization of a glycosylated \u03b2-peptide 314-helix conveying the TN-antigen","volume":"3","author":"Norgren","year":"2005","journal-title":"Org. Biomol. Chem."},{"issue":"40","key":"10.1016\/j.biotechadv.2023.108144_bb0870","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1002\/anie.201304212","article-title":"Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines","volume":"52","author":"Nuhn","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0875","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1749-6632.1999.tb09435.x","article-title":"Peptides mimicking sialyl-Lewis A isolated from a random peptide library and peptide array","volume":"886","author":"O, I","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb0880","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1039\/C1CC15139H","article-title":"Antibody recognition of fluorinated MUC1 glycopeptide antigens","volume":"48","author":"Oberbillig","year":"2012","journal-title":"Chem. Commun. (Camb.)"},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb0885","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cancers8040046","article-title":"A phase I study of unimolecular pentavalent (Globo-H-GM2-sTn-TF-Tn) immunization of patients with epithelial ovarian, fallopian tube, or peritoneal cancer in first remission","volume":"8","author":"O\u2019Cearbhaill","year":"2016","journal-title":"Cancers"},{"issue":"3\u20134","key":"10.1016\/j.biotechadv.2023.108144_bb0890","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.carres.2006.11.018","article-title":"Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines","volume":"342","author":"Ojeda","year":"2007","journal-title":"Carbohydr. Res."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb0895","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cbpa.2010.11.022","article-title":"Glycosyltransferases as biocatalysts","volume":"15","author":"Palcic","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"17","key":"10.1016\/j.biotechadv.2023.108144_bb0900","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1021\/acs.chemrev.8b00051","article-title":"Automated chemical oligosaccharide synthesis: novel approach to traditional challenges","volume":"118","author":"Panza","year":"2018","journal-title":"Chem. Rev."},{"issue":"25","key":"10.1016\/j.biotechadv.2023.108144_bb0905","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1021\/ja4046857","article-title":"\u2018Multicopy multivalent\u2019 glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines","volume":"135","author":"Parry","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.biotechadv.2023.108144_bb0910","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2174\/156802605774370928","article-title":"Carbohydrate mimotopes in the rational design of cancer vaccines","volume":"5","author":"Pashov","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"issue":"25\u201326","key":"10.1016\/j.biotechadv.2023.108144_bb0915","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.vaccine.2009.01.074","article-title":"Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes","volume":"27","author":"Pashov","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb0920","first-page":"1954","article-title":"Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice","volume":"52","author":"Peat","year":"1992","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0925","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/ijc.25778","article-title":"Seromic profiling of colorectal cancer patients with novel glycopeptide microarray","volume":"128","author":"Pedersen","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0930","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.20082492","article-title":"Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies","volume":"206","author":"Peggs","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0935","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fonc.2019.00380","article-title":"Protein glycosylation and tumor microenvironment alterations driving Cancer hallmarks","volume":"9","author":"Peixoto","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-73119-9_1","article-title":"The tumour microenvironment and circulating tumour cells: a partnership driving metastasis and glycan-based opportunities for cancer control","volume":"1329","author":"Peixoto","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0945","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-021-01988-6","article-title":"Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer","volume":"40","author":"Peixoto","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0950","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13046-022-02335-z","article-title":"A roadmap for translational cancer glycoimmunology at single cell resolution","volume":"41","author":"Peixoto","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0955","first-page":"540","article-title":"Glycosylation in cancer\u202f: mechanisms and clinical implications","volume":"16","author":"Pinho","year":"2015","journal-title":"Nat. Publ. Group"},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb0960","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb0965","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.febslet.2006.01.063","article-title":"GD3-replica peptides selected from a phage peptide library induce a GD3 ganglioside antibody response","volume":"580","author":"Popa","year":"2006","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0970","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20092618","article-title":"Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells","volume":"207","author":"Poulin","year":"2010","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb0975","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0980","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/hyb.1999.18.103","article-title":"Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines","volume":"18","author":"Qiu","year":"1999","journal-title":"Hybridoma"},{"key":"10.1016\/j.biotechadv.2023.108144_bb0985","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.668731","article-title":"Cancer-associated fibroblasts and tumor-associated macrophages in cancer and cancer immunotherapy","volume":"11","author":"Raskov","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb0990","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103755","article-title":"Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice","volume":"9","author":"Rauen","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb0995","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40425-018-0409-8","article-title":"Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancer","volume":"6","author":"Redman","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1000","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/cmdc.200700315","article-title":"Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine","volume":"3","author":"Renaudet","year":"2008","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011216","article-title":"Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity","volume":"5","author":"Renaudet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2023.108144_bb1010","first-page":"231","article-title":"Enzymatic synthesis of glycans and glycoconjugates","volume":"175","author":"Rexer","year":"2021","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1015","series-title":"Glycoscience: Chemistry and Chemical Biology","first-page":"2645","article-title":"Mucin-based vaccines","author":"Richardson","year":"2008"},{"issue":"44","key":"10.1016\/j.biotechadv.2023.108144_bb1020","doi-asserted-by":"crossref","first-page":"11917","DOI":"10.1002\/anie.201406897","article-title":"A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity","volume":"53","author":"Richichi","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051340","article-title":"Mechanisms of intrinsic tumor resistance to immunotherapy","volume":"19","author":"Rieth","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.biotechadv.2023.108144_bb1030","first-page":"30121","article-title":"Glycosylation in cancer: selected roles in tumour progression, immune modulation and metastasis","volume":"8749","author":"Rodrigues","year":"2018","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb1035","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1042\/BST20200763","article-title":"Aberrant protein glycosylation in cancer: implications in targeted therapy","volume":"49","author":"Rodrigues","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"Rodr\u00cdguez","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1045","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1038\/s41467-019-11131-x","article-title":"Towards a standardized bioinformatics infrastructure for N- and O-glycomics","volume":"10","author":"Rojas-Macias","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00262-020-02503-0","article-title":"The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients","volume":"69","author":"Rosenbaum","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/1097-0215(20000701)87:1<79::AID-IJC12>3.0.CO;2-L","article-title":"Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial","volume":"87","author":"Sabbatini","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biotechadv.2023.108144_bb1065","series-title":"Essentials of Glycobiology. Cold Spring Harbor (NY)","first-page":"615","article-title":"Glycans in acquired human diseases","author":"Sackstein","year":"2022"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12934-021-01588-1","article-title":"Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli","volume":"20","author":"Samaras","year":"2021","journal-title":"Microb. Cell Factories"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb1075","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1172\/JCI34584","article-title":"Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin","volume":"118","author":"Sancho","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01496","article-title":"Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell response","volume":"9","author":"Sartorius","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb1085","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.drudis.2018.03.003","article-title":"A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy","volume":"23","author":"Sau","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb1090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.biotechadv.2023.108144_bb1095","doi-asserted-by":"crossref","first-page":"28312","DOI":"10.18632\/oncotarget.16048","article-title":"HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model","volume":"8","author":"Schr\u00f6rs","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1100","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4049\/jimmunol.1400489","article-title":"Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk","volume":"193","author":"Sehgal","year":"2014","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb1105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0167-5699(00)01692-3","article-title":"Antigen-processing machinery breakdown and tumor growth","volume":"21","author":"Seliger","year":"2000","journal-title":"Immunol. Today"},{"issue":"12","key":"10.1016\/j.biotechadv.2023.108144_bb1110","doi-asserted-by":"crossref","DOI":"10.3390\/md18120605","article-title":"The application of mucoadhesive chitosan nanoparticles in nasal drug delivery","volume":"18","author":"Shim","year":"2020","journal-title":"Mar. Drugs"},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb1115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00262-004-0598-5","article-title":"Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer","volume":"54","author":"Slovin","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb1120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bmc.2016.01.015","article-title":"Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates","volume":"24","author":"Song","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"29","key":"10.1016\/j.biotechadv.2023.108144_bb1125","doi-asserted-by":"crossref","first-page":"47330","DOI":"10.18632\/oncotarget.17646","article-title":"A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model","volume":"8","author":"Song","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10719-019-09884-0","article-title":"Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response","volume":"36","author":"Song","year":"2019","journal-title":"Glycoconj. J."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb1135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/glycob\/cwj044","article-title":"Chemoenzymatically synthesized multimeric Tn\/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance","volume":"16","author":"S\u00f8rensen","year":"2005","journal-title":"Glycobiology"},{"issue":"48","key":"10.1016\/j.biotechadv.2023.108144_bb1140","doi-asserted-by":"crossref","first-page":"E7759","DOI":"10.1073\/pnas.1609376113","article-title":"Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma","volume":"113","author":"Spranger","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"669","key":"10.1016\/j.biotechadv.2023.108144_bb1145","doi-asserted-by":"crossref","first-page":"eabj1270","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"45","key":"10.1016\/j.biotechadv.2023.108144_bb1150","doi-asserted-by":"crossref","first-page":"13198","DOI":"10.1002\/anie.201506112","article-title":"Sugar-protein connectivity impacts on the immunogenicity of site-selective Salmonella O-antigen glycoconjugate vaccines","volume":"54","author":"Stefanetti","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/2326-6066.CIR-18-0256","article-title":"Reduced breast tumor growth after immunization with a tumor-restricted MUC1 glycopeptide conjugated to tetanus toxoid","volume":"7","author":"Stergiou","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"48","key":"10.1016\/j.biotechadv.2023.108144_bb1160","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1039\/C6CC02000C","article-title":"Multi-component self-assembled anti-tumor nano-vaccines based on MUC1 glycopeptides","volume":"52","author":"Sun","year":"2016","journal-title":"Chem. Commun."},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1165","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051100","article-title":"Glycosylation of immune receptors in cancer","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1170","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"31","key":"10.1016\/j.biotechadv.2023.108144_bb1175","doi-asserted-by":"crossref","first-page":"17535","DOI":"10.1021\/acsami.5b05497","article-title":"Lipopeptide-coated iron oxide nanoparticles as potential glycoconjugate-based synthetic anticancer vaccines","volume":"7","author":"Sungsuwan","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb1180","first-page":"479","article-title":"A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I","volume":"161","author":"Sutoh Yoneyama","year":"2017","journal-title":"J. Biochem."},{"issue":"15","key":"10.1016\/j.biotechadv.2023.108144_bb1185","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2011-04-346957","article-title":"Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation","volume":"118","author":"Tacken","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbagen.2008.01.005","article-title":"A new approach for drug discovery from glycobiology and phage-displayed peptide library technology","volume":"1780","author":"Taki","year":"2008","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"2","key":"10.1016\/j.biotechadv.2023.108144_bb1195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/med.21625","article-title":"Design and synthesis of glycomimetics: recent advances","volume":"40","author":"Tamburrini","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb1200","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/eji.1830270942","article-title":"Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells","volume":"27","author":"Tan","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/BST20170400","article-title":"Latest developments in MUC1 immunotherapy","volume":"46","author":"Taylor-Papadimitriou","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb1215","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1111\/jcmm.14572","article-title":"Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells","volume":"23","author":"Thomas","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"14","key":"10.1016\/j.biotechadv.2023.108144_bb1220","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/cbic.200700208","article-title":"Synthesis, conformational studies, binding assessment and liposome insertion of a thioether-bridged mimetic of the antigen GM3 ganglioside lactone","volume":"8","author":"Toma","year":"2007","journal-title":"Chembiochem"},{"issue":"7","key":"10.1016\/j.biotechadv.2023.108144_bb1225","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.chembiol.2019.03.018","article-title":"Vaccination with tumor-ganglioside Glycomimetics activates a selective immunity that affords cancer therapy","volume":"26","author":"Tong","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1230","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/ja00080a055","article-title":"Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins","volume":"116","author":"Toyokuni","year":"1994","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acsbiomedchemau.1c00021","article-title":"Stable gold-nanoparticle-based vaccine for the targeted delivery of tumor-associated glycopeptide antigens","volume":"1","author":"Trabbic","year":"2021","journal-title":"ACS Bio. Med. Chem. Au"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.coi.2010.11.011","article-title":"\u2018Dressed for success\u2019 C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells","volume":"23","author":"Unger","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1245","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821000261","volume":"149","author":"van der Vliet","year":"2021","journal-title":"Epidemiol. Infect."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb1250","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1189\/jlb.5MR0217-059RR","article-title":"Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines","volume":"102","author":"van Dinther","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1255","series-title":"Essentials of Glycobiology","article-title":"Glycosylation changes in cancer","author":"Varki","year":"2009"},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb1260","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2217\/imt.13.126","article-title":"Up to 15-year clinical follow-up of a pilot phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1","volume":"5","author":"Vassilaros","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.biotechadv.2023.108144_bb1265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2019.00008","article-title":"Vaccine strategies to improve anti-cancer cellular immune responses","volume":"10","author":"Vermaelen","year":"2019","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.biotechadv.2023.108144_bb1270","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1016\/j.bmcl.2004.04.047","article-title":"Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen","volume":"14","author":"Vichier-Guerre","year":"2004","journal-title":"Bioorgan. Med. Chem. Lett."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1275","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-9-357","article-title":"ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines","volume":"9","author":"Videira","year":"2009","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bib1421","doi-asserted-by":"crossref","first-page":"090","DOI":"10.4172\/jpb.1000218","article-title":"N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients","volume":"5","author":"Wang","year":"2012","journal-title":"J Proteomics Bioinform."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb1280","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb1285","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/0008-5472.CAN-09-2893","article-title":"Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes","volume":"70","author":"Wandall","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/cb200358r","article-title":"Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse","volume":"7","author":"Wang","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"17","key":"10.1016\/j.biotechadv.2023.108144_bb1295","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1021\/acs.chemrev.8b00066","article-title":"Toward automated enzymatic synthesis of oligosaccharides","volume":"118","author":"Wen","year":"2018","journal-title":"Chem. Rev."},{"issue":"39","key":"10.1016\/j.biotechadv.2023.108144_bb1300","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1002\/anie.200802102","article-title":"Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response","volume":"47","author":"Westerlind","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.biotechadv.2023.108144_bb1305","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0196-9781(99)00095-9","article-title":"Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside","volume":"20","author":"Willers","year":"1999","journal-title":"Peptides"},{"issue":"39","key":"10.1016\/j.biotechadv.2023.108144_bb1310","doi-asserted-by":"crossref","first-page":"14462","DOI":"10.1021\/ja405932r","article-title":"A vision for vaccines built from fully synthetic tumor-associated antigens: from the laboratory to the clinic","volume":"135","author":"Wilson","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1315","doi-asserted-by":"crossref","first-page":"43486","DOI":"10.1038\/srep43486","article-title":"Monitoring of dynamic changes in keyhole limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients","volume":"7","author":"Wimmers","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1320","doi-asserted-by":"crossref","DOI":"10.1002\/imed.1020","article-title":"Next generation therapeutic strateg-Es: evolving cancer immunotherapy through agents that engage, expand and enable the anti-tumor immune response","volume":"1","author":"Wolfson","year":"2021","journal-title":"ImmunoMedicine"},{"issue":"5","key":"10.1016\/j.biotechadv.2023.108144_bb1325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/vaccines9050509","article-title":"Stay on target: reengaging cancer vaccines in combination immunotherapy","volume":"9","author":"Wolfson","year":"2021","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.biotechadv.2023.108144_bb1330","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/acschembio.9b00381","article-title":"Synthesis and immunological evaluation of disaccharide bearing MUC-1 glycopeptide conjugates with virus-like particles","volume":"14","author":"Wu","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116126","article-title":"Chitosan-based colloidal polyelectrolyte complexes for drug delivery: a review","volume":"238","author":"Wu","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"11","key":"10.1016\/j.biotechadv.2023.108144_bb1340","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1039\/D1OB00007A","article-title":"Synthesis and immunological evaluation of the unnatural \u03b2-linked mucin-1 Thomsen-Friedenreich conjugate","volume":"19","author":"Wu","year":"2021","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Sign. Transduct. Target. Therap."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1350","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/cb100287q","article-title":"Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen","volume":"6","author":"Yang","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb1355","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nbt.3280","article-title":"Engineered CHO cells for production of diverse, homogeneous glycoproteins","volume":"33","author":"Yang","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1360","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1021\/acsmacrolett.2c00291","article-title":"Liposome-based carbohydrate vaccine for simultaneously eliciting humoral and cellular antitumor immunity","author":"Yao","year":"2022","journal-title":"ACS Macro Lett."},{"issue":"8","key":"10.1016\/j.biotechadv.2023.108144_bb1365","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1021\/bc300244a","article-title":"Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens","volume":"23","author":"Yin","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"6","key":"10.1016\/j.biotechadv.2023.108144_bb1370","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/cb400060x","article-title":"Boosting immunity to small tumor-associated carbohydrates with bacteriophage qbeta capsids","volume":"8","author":"Yin","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1380","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/acs.orglett.6b03591","article-title":"IgG antibody response elicited by a fully synthetic two-component carbohydrate-based cancer vaccine candidate with \u03b1-Galactosylceramide as built-in adjuvant","volume":"19","author":"Yin","year":"2017","journal-title":"Org. Lett."},{"issue":"4","key":"10.1016\/j.biotechadv.2023.108144_bb1385","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/eji.200838871","article-title":"Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice","volume":"39","author":"Zaccone","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biotechadv.2023.108144_bb1390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786286","article-title":"Intercepting premalignant, preinvasive breast lesions through vaccination","volume":"12","author":"Zachariah","year":"2021","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.biotechadv.2023.108144_bb1395","first-page":"3364","article-title":"Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen","volume":"55","author":"Zhang","year":"1995","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.biotechadv.2023.108144_bb1405","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.3390\/cells11223666","article-title":"A sweet warning: mucin-type O-glycans in cancer","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biotechadv.2023.108144_bb1410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1415","doi-asserted-by":"crossref","first-page":"11403","DOI":"10.1038\/s41598-017-11500-w","article-title":"Synthesis and evaluation of GM2-monophosphoryl lipid A conjugate as a fully synthetic self-adjuvant cancer vaccine","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biotechadv.2023.108144_bb1420","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41467-017-00784-1","article-title":"Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975023000514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975023000514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:15:03Z","timestamp":1760012103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975023000514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":283,"alternative-id":["S0734975023000514"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2023.108144","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2023.108144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108144"}}